Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)

10.1200/JCO.2017.77.0388

Saved in:
Bibliographic Details
Main Authors: Ma, Brigette BY, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex YC, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, KC Allen, Lo, YM Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony TC
Other Authors: MEDICINE
Format: Article
Language:English
Published: AMER SOC CLINICAL ONCOLOGY 2024
Subjects:
Online Access:https://scholarbank.nus.edu.sg/handle/10635/248960
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore
Language: English
id sg-nus-scholar.10635-248960
record_format dspace
spelling sg-nus-scholar.10635-2489602024-11-11T21:42:39Z Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742) Ma, Brigette BY Lim, Wan-Teck Goh, Boon-Cher Hui, Edwin P Lo, Kwok-Wai Pettinger, Adam Foster, Nathan R Riess, Jonathan W Agulnik, Mark Chang, Alex YC Chopra, Akhil Kish, Julie A Chung, Christine H Adkins, Douglas R Cullen, Kevin J Gitlitz, Barbara J Lim, Dean W To, Ka-Fai Chan, KC Allen Lo, YM Dennis King, Ann D Erlichman, Charles Yin, Jun Costello, Brian A Chan, Anthony TC MEDICINE DUKE-NUS MEDICAL SCHOOL Science & Technology Life Sciences & Biomedicine Oncology BARR-VIRUS DNA PD-L1 EXPRESSION CELL CARCINOMA THERAPY CANCER MELANOMA MUTATIONS BLOCKADE ESCAPE SUBSET 10.1200/JCO.2017.77.0388 JOURNAL OF CLINICAL ONCOLOGY 36 14 1412-+ 2024-06-19T03:21:11Z 2024-06-19T03:21:11Z 2018-05-10 2024-06-12T14:05:59Z Article Ma, Brigette BY, Lim, Wan-Teck, Goh, Boon-Cher, Hui, Edwin P, Lo, Kwok-Wai, Pettinger, Adam, Foster, Nathan R, Riess, Jonathan W, Agulnik, Mark, Chang, Alex YC, Chopra, Akhil, Kish, Julie A, Chung, Christine H, Adkins, Douglas R, Cullen, Kevin J, Gitlitz, Barbara J, Lim, Dean W, To, Ka-Fai, Chan, KC Allen, Lo, YM Dennis, King, Ann D, Erlichman, Charles, Yin, Jun, Costello, Brian A, Chan, Anthony TC (2018-05-10). Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742). JOURNAL OF CLINICAL ONCOLOGY 36 (14) : 1412-+. ScholarBank@NUS Repository. https://doi.org/10.1200/JCO.2017.77.0388 0732-183X 1527-7755 https://scholarbank.nus.edu.sg/handle/10635/248960 en AMER SOC CLINICAL ONCOLOGY Elements
institution National University of Singapore
building NUS Library
continent Asia
country Singapore
Singapore
content_provider NUS Library
collection ScholarBank@NUS
language English
topic Science & Technology
Life Sciences & Biomedicine
Oncology
BARR-VIRUS DNA
PD-L1 EXPRESSION
CELL CARCINOMA
THERAPY
CANCER
MELANOMA
MUTATIONS
BLOCKADE
ESCAPE
SUBSET
spellingShingle Science & Technology
Life Sciences & Biomedicine
Oncology
BARR-VIRUS DNA
PD-L1 EXPRESSION
CELL CARCINOMA
THERAPY
CANCER
MELANOMA
MUTATIONS
BLOCKADE
ESCAPE
SUBSET
Ma, Brigette BY
Lim, Wan-Teck
Goh, Boon-Cher
Hui, Edwin P
Lo, Kwok-Wai
Pettinger, Adam
Foster, Nathan R
Riess, Jonathan W
Agulnik, Mark
Chang, Alex YC
Chopra, Akhil
Kish, Julie A
Chung, Christine H
Adkins, Douglas R
Cullen, Kevin J
Gitlitz, Barbara J
Lim, Dean W
To, Ka-Fai
Chan, KC Allen
Lo, YM Dennis
King, Ann D
Erlichman, Charles
Yin, Jun
Costello, Brian A
Chan, Anthony TC
Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
description 10.1200/JCO.2017.77.0388
author2 MEDICINE
author_facet MEDICINE
Ma, Brigette BY
Lim, Wan-Teck
Goh, Boon-Cher
Hui, Edwin P
Lo, Kwok-Wai
Pettinger, Adam
Foster, Nathan R
Riess, Jonathan W
Agulnik, Mark
Chang, Alex YC
Chopra, Akhil
Kish, Julie A
Chung, Christine H
Adkins, Douglas R
Cullen, Kevin J
Gitlitz, Barbara J
Lim, Dean W
To, Ka-Fai
Chan, KC Allen
Lo, YM Dennis
King, Ann D
Erlichman, Charles
Yin, Jun
Costello, Brian A
Chan, Anthony TC
format Article
author Ma, Brigette BY
Lim, Wan-Teck
Goh, Boon-Cher
Hui, Edwin P
Lo, Kwok-Wai
Pettinger, Adam
Foster, Nathan R
Riess, Jonathan W
Agulnik, Mark
Chang, Alex YC
Chopra, Akhil
Kish, Julie A
Chung, Christine H
Adkins, Douglas R
Cullen, Kevin J
Gitlitz, Barbara J
Lim, Dean W
To, Ka-Fai
Chan, KC Allen
Lo, YM Dennis
King, Ann D
Erlichman, Charles
Yin, Jun
Costello, Brian A
Chan, Anthony TC
author_sort Ma, Brigette BY
title Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
title_short Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
title_full Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
title_fullStr Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
title_full_unstemmed Antitumor Activity of Nivolumab in Recurrent and Metastatic Nasopharyngeal Carcinoma: An International, Multicenter Study of the Mayo Clinic Phase 2 Consortium (NCI-9742)
title_sort antitumor activity of nivolumab in recurrent and metastatic nasopharyngeal carcinoma: an international, multicenter study of the mayo clinic phase 2 consortium (nci-9742)
publisher AMER SOC CLINICAL ONCOLOGY
publishDate 2024
url https://scholarbank.nus.edu.sg/handle/10635/248960
_version_ 1821216357034754048